Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedCore content updated with a government-operational notice and a version bump from v3.1.0 to v3.2.0; no other significant content changes detected.SummaryDifference6%

- Check36 days agoChange DetectedPage updated to version v3.1.0 and added contact details (email and phone); previous version v3.0.2 removed.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.0.2 added, replacing v3.0.1; the 'Back to Top' element was removed.SummaryDifference0.4%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.4%

- Check64 days agoChange DetectedThe web page has updated its facility name and location details, including specific references to Beijing and related medical topics, while removing previous location terms and some drug references.SummaryDifference2%

- Check79 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.